data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
NovoCure
(NASDAQ:NVCR)
$73.30
00
At close: Jul 1
$71.50
-1.8000[-2.46%]
PreMarket: 6:04AM EDT
Day High/Low- - -
52 Week High/Low56.39 - 207.48
Open / Close- / -
Float / Outstanding78.9M / 104.6M
Vol / Avg.0.2K / 686.7K
Mkt Cap7.7B
P/E-
50d Avg. Price72.58
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float78.9M

NovoCure (NASDAQ:NVCR), Quotes and News Summary

NovoCure (NASDAQ: NVCR)

Day High/Low- - -
52 Week High/Low56.39 - 207.48
Open / Close- / -
Float / Outstanding78.9M / 104.6M
Vol / Avg.0.2K / 686.7K
Mkt Cap7.7B
P/E-
50d Avg. Price72.58
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float78.9M
Benzinga - Jun 21, 2022, 5:38PM
Benzinga - Jun 21, 2022, 8:05AM
Benzinga - Jun 3, 2022, 8:01AM
Benzinga - May 26, 2022, 8:10AM
Benzinga - May 16, 2022, 6:05AM
Benzinga - May 13, 2022, 6:27AM
Benzinga - Apr 28, 2022, 7:11AM
Benzinga - Apr 28, 2022, 7:10AM
Benzinga - Apr 8, 2022, 7:02AM
Benzinga - Mar 25, 2022, 7:50AM
Benzinga - Mar 24, 2022, 4:00PM
Benzinga - Mar 23, 2022, 8:01AM
Benzinga - Feb 24, 2022, 12:15PM
Benzinga - Feb 24, 2022, 7:58AM
Benzinga - Feb 24, 2022, 7:24AM
Benzinga - Feb 8, 2022, 4:42AM
Benzinga - Feb 2, 2022, 8:31AM
Benzinga - Jan 20, 2022, 12:06PM
Benzinga - Jan 20, 2022, 7:22AM
Benzinga - Jan 11, 2022, 7:01AM
Benzinga - Jan 10, 2022, 7:40AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-28
REV
Q1 2022Est.ActualSurprise
EPS-0.180-0.040 0.1400
REV134.080M137.547M3.467M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

NovoCure Questions & Answers

Q
How do I buy NovoCure (NVCR) stock?
A

You can purchase shares of NovoCure (NASDAQ: NVCR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are NovoCure's (NVCR) competitors?
Q
What is the target price for NovoCure (NVCR) stock?
A

The latest price target for NovoCure (NASDAQ: NVCR) was reported by HC Wainwright & Co. on Monday, May 16, 2022. The analyst firm set a price target for 115.00 expecting NVCR to rise to within 12 months (a possible 56.89% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for NovoCure (NVCR)?
A

The stock price for NovoCure (NASDAQ: NVCR) is $73.3 last updated July 1, 2022, 8:00 PM UTC.

Q
Does NovoCure (NVCR) pay a dividend?
A

There are no upcoming dividends for NovoCure.

Q
When is NovoCure (NASDAQ:NVCR) reporting earnings?
A

NovoCure’s Q2 earnings are confirmed for Thursday, July 28, 2022.

Q
Is NovoCure (NVCR) going to split?
A

There is no upcoming split for NovoCure.

Q
What sector and industry does NovoCure (NVCR) operate in?
A

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.